170 related articles for article (PubMed ID: 25281284)
1. Is the pharmacy profession innovative enough?: meeting the needs of Australian residents with chronic conditions and their carers using the nominal group technique.
McMillan SS; Sav A; Kelly F; King MA; Whitty JA; Wheeler AJ
BMC Health Serv Res; 2014 Oct; 14():476. PubMed ID: 25281284
[TBL] [Abstract][Full Text] [Related]
2. Consumers and Carers Versus Pharmacy Staff: Do Their Priorities for Australian Pharmacy Services Align?
McMillan SS; Kelly F; Sav A; Kendall E; King MA; Whitty JA; Wheeler AJ
Patient; 2015 Oct; 8(5):411-22. PubMed ID: 25512020
[TBL] [Abstract][Full Text] [Related]
3. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important.
McMillan SS; Kelly F; Sav A; King MA; Whitty JA; Wheeler AJ
BMJ Open; 2014 Dec; 4(12):e006587. PubMed ID: 25488098
[TBL] [Abstract][Full Text] [Related]
4. A pharmacy carer support service: obtaining new insight into carers in the community.
McMillan SS; King MA; Stapleton H; Sav A; Kelly F; Wheeler AJ
Int J Pharm Pract; 2019 Feb; 27(1):34-44. PubMed ID: 29732644
[TBL] [Abstract][Full Text] [Related]
5. Australian mental health consumers and carers expect more health management information from community pharmacy.
Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
[TBL] [Abstract][Full Text] [Related]
6. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
8. Community pharmacy in Australia: a health hub destination of the future.
McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F
Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552
[TBL] [Abstract][Full Text] [Related]
9. Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
Green TC; Case P; Fiske H; Baird J; Cabral S; Burstein D; Schwartz V; Potter N; Walley AY; Bratberg J
J Am Pharm Assoc (2003); 2017; 57(2S):S19-S27.e4. PubMed ID: 28214219
[TBL] [Abstract][Full Text] [Related]
10. A qualitative exploration of mental health services provided in community pharmacies.
Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
[TBL] [Abstract][Full Text] [Related]
11. Support for Australian carers from community pharmacy: Insight into carer perspectives of a novel service.
McMillan SS; King MA; Sav A; Wheeler AJ; Kelly F
Health Soc Care Community; 2019 Mar; 27(2):320-329. PubMed ID: 30187990
[TBL] [Abstract][Full Text] [Related]
12. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
Taylor S; Cairns A; Glass B
Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
[TBL] [Abstract][Full Text] [Related]
13. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
14. Implementation of diabetes screening in community pharmacy - factors influencing successful implementation.
Siu AHY; Krass I; Mitchell B; McNamara K
Res Social Adm Pharm; 2021 Sep; 17(9):1606-1613. PubMed ID: 33414090
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
Singh HK; Kennedy GA; Stupans I
Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
[TBL] [Abstract][Full Text] [Related]
16. A qualitative exploration of the barriers and enablers to supporting informal and familial carers within community pharmacies.
Richardson CL; Edwards K; Lunny J; Lindsey L
Int J Pharm Pract; 2024 May; 32(3):201-207. PubMed ID: 38394367
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist's time spent: Space for Pharmacy-based Interventions and Consultation TimE (SPICE)-an observational time and motion study.
Karia A; Norman R; Robinson S; Lehnbom E; Laba TL; Durakovic I; Balane C; Joshi R; Webster R
BMJ Open; 2022 Mar; 12(3):e055597. PubMed ID: 35236731
[TBL] [Abstract][Full Text] [Related]
18. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
20. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
Hanes CA; Wong KK; Saini B
Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
